Current Allergy and Asthma Reports

, Volume 5, Issue 2, pp 116–122 | Cite as

Exercise-induced bronchoconstriction: Pathogenesis

  • Sandra D. Anderson
  • Pascale Kippelen


There is still active debate on the acute mechanism of exercise-induced bronchoconstriction (EIB). Although it is unlikely that vasoconstriction and hyperemia of the bronchial vasculature are essential events for EIB, it is likely that this vasculature enhances the airway response to dehydration and contributes to the pathogenesis of EIB, particularly in elite athletes. Accumulating evidence suggests that airway smooth muscle (ASM) becomes more sensitive as a result of repeated exposure to bulk plasma in response to airway injury from dehydration. Recent evidence also demonstrates sufficient concentrations of mediators that could affect ASM. Paradoxically, mediator release from mast cells may be enhanced and their contractile effects greater when β2-receptor agonists are taken daily. The effect of drugs that have the potential to reduce microvascular leak and reduce or inhibit release or action of these mediators needs to be investigated in elite athletes.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Anderson SD, Holzer K: Exercise-induced asthma: Is it the right diagnosis in elite athletes? J Allergy Clin Immunol 2000, 106:419–428.PubMedCrossRefGoogle Scholar
  2. 2.
    Brannan JD, Gulliksson M, Anderson SD, et al.: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003, 22:491–496. The first study to demonstrate a significant increase in urinary excretion of leukotrienes and prostaglandins in healthy subjects in response to an osmotic stimulus.PubMedCrossRefGoogle Scholar
  3. 3.
    Caillaud C, Le Creff C, Legros P, et al.: Strenuous exercise increases plasmatic and urinary leukotriene E4 in cyclists. Can J Appl Physiol 2003, 28:793–806. The first study to demonstrate increases in urinary excretion of leukotrienes and plasma levels in highly trained healthy subjects who exercise intensely.PubMedGoogle Scholar
  4. 4.
    Mickleborough TD, Murray RL, Ionescu AA, et al.: Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003, 168:1181–1189. The first study to demonstrate an association between exerciseinduced bronchoconstriction, changes in urinary excretion of leukotrienes and prostaglandins, and diet in healthy subjects.PubMedCrossRefGoogle Scholar
  5. 5.
    McFadden ER, Lenner KA, Strohl KP: Postexertional airway rewarming and thermally induced asthma. J Clin Invest 1986, 78:18–25.PubMedCrossRefGoogle Scholar
  6. 6.
    Anderson SD: Is there a unifying hypothesis for exerciseinduced asthma? J Allergy Clin Immunol 1984, 73:660–665.PubMedCrossRefGoogle Scholar
  7. 7.
    Daviskas E, Anderson SD, Gonda I, et al.: Changes in mucociliary clearance during and after isocapnic hyperventilation in asthmatic and healthy subjects. Eur Respir J 1995, 8:742–751.PubMedGoogle Scholar
  8. 8.
    McFadden ER, Nelson JA, Skowronski ME, et al.: Thermally induced asthma and airway drying. Am J Respir Crit Care Med 1999, 160:221–226.PubMedGoogle Scholar
  9. 9.
    Kotaru C, Hejal RB, Finigan JH, et al.: Desiccation and hypertonicity of the airway surface fluid and thermally induced asthma. J Appl Physiol 2003, 94:227–233.PubMedGoogle Scholar
  10. 10.
    Freed AN, Davis MS: Hyperventilation with dry air increases airway surface fluid osmolality in canine peripheral airways. Am J Respir Crit Care Med 1999, 159:1101–1107.PubMedGoogle Scholar
  11. 11.
    Davis MS, Daviskas E, Anderson SD, et al.: Airway surface fluid desiccation during isocapnic hyperpnea. J Appl Physiol 2003, 94:2545–2547.PubMedGoogle Scholar
  12. 12.
    Anderson SD, Daviskas E: The mechanism of exercise-induced asthma is … J Allergy Clin Immunol 2000, 106:453–459.PubMedCrossRefGoogle Scholar
  13. 13.
    Sue-Chu M, Larsson L, Bjermer L: Prevalence of asthma in young cross-country skiers in central Scandinavia: differences between Norway and Sweden. Respir Med 1996, 90:99–105.PubMedCrossRefGoogle Scholar
  14. 14.
    Helenius IJ, Tikkanen HO, Sarna S, et al.: Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol 1998, 101:646–652.PubMedCrossRefGoogle Scholar
  15. 15.
    Langdeau J-B, Turcotte H, Bowie DM, et al.: Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med 2000, 161:1479–1484.PubMedGoogle Scholar
  16. 16.
    Rundell KW, Im J, Mayers LB, et al.: Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc 2001, 33:208–213.PubMedGoogle Scholar
  17. 17.
    Anderson SD, Fitch K, Perry CP, et al.: Responses to bronchial challenge submitted for approval to use inhaled beta2 agonists prior to an event at the 2002 Winter Olympics. J Allergy Clin Immunol 2003, 111:44–49.CrossRefGoogle Scholar
  18. 18.
    Rundell KW: High levels of airborne ultrafine and fine particulate matter in indoor ice arenas. Inhal Toxicol 2003, 15:237–250.PubMedCrossRefGoogle Scholar
  19. 19.
    Pliss LB, Ingenito EP, Ingram RH, et al.: Assessment of bronchoalveolar cell and mediator response to isocapnic hyperpnea in asthma. Am Rev Respir Dis 1990, 142:73–78.PubMedGoogle Scholar
  20. 20.
    Hallstrand TS, Moody MM, Aitken ML, Henderson WR: Characteristics of airway inflammation in the exercise-induced bronchoconstriction asthma sub-phenotype (abstract). Am J Respir Crit Care Med 2004, A817.Google Scholar
  21. 21.
    Omori C, Schofield BH, Mitzner W, et al.: Hyperpnea with dry air causes time-dependent alterations in mucosal morphology and bronchovascular permeability. J Appl Physiol 1995, 78:1043–1051.PubMedGoogle Scholar
  22. 22.
    Davis MS, Freed AN: Repeated hyperventilation causes peripheral airways inflammation, hyperreactivity, and impaired bronchodilation in dogs. Am J Respir Crit Care Med 2001, 164:785–789.PubMedGoogle Scholar
  23. 23.
    Omori C, Schofield BH, Mitzner W, et al.: A beta2-adrenergic agonist inhibits dry air-induced injury in canine peripheral airways. J Appl Physiol 1995, 78:2169–2179.PubMedGoogle Scholar
  24. 24.
    Persson CGA, Erjefalt JS: Airway epithelial restitution after shedding and denudation. In The Lung, 2nd ed. Edited by Crystal RG, West JB, Weibel ER, Barnes PJ. New York: Raven Press; 1997:2611–2627.Google Scholar
  25. 25.
    Sue-Chu M, Larsson L, Moen T, et al.: Bronchoscopy and bronchoalveolar lavage findings in cross-country skiers with and without "ski asthma". Eur Respir J 1999, 13:626–632.PubMedCrossRefGoogle Scholar
  26. 26.
    Larsson K, Tornling G, Gavhed D, et al.: Inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects. Eur Respir J 1998, 12:825–830.PubMedCrossRefGoogle Scholar
  27. 27.
    Karjalainen E-M, Laitinen A, Sue-Chu M, et al.: Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med 2000, 161:2086–2091.PubMedGoogle Scholar
  28. 28.
    Bonsignore MR, Morici G, Riccobono L, et al.: Airway inflammation in nonasthmatic amateur runners. Am J Physiol Lung Cell Mol Physiol 2001, 281:L668-L676.PubMedGoogle Scholar
  29. 29.
    Obase Y, Helenius I, Rytila P, et al.: MMP-8 and TIMP-1 expressions in induced sputum in elite hockey players and nonathletes with and without asthma (abstract). Eur Respir J 2004, 24(Supp 48):ASM.Google Scholar
  30. 30.
    Kanazawa H, Hirata K, Yoshikawa J: Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 2002, 57:885–888.PubMedCrossRefGoogle Scholar
  31. 31.
    Johnson PR, Burgess JK: Airway smooth muscle and fibroblasts in the pathogenesis of asthma. Curr Allergy Asthma Rep 2004, 4:102–108.PubMedGoogle Scholar
  32. 32.
    Sue-Chu M, Brannan JD, Anderson SD, et al.: Airway responsiveness to methacholine, adenosine monophosphate (AMP), mannitol, eucapnic voluntary hyperpnea and sport specific field exercise challenge in cross country ski athletes (abstract). Eur Respir J 2002, ASM.Google Scholar
  33. 33.
    Helenius IJ, Tikkanen HO, Haahtela T: Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med 1998, 32:125–129.PubMedCrossRefGoogle Scholar
  34. 34.
    Page S, Ammit AJ, Black JL, et al.: Human mast cells and airway smooth muscle cell interactions: implications for asthma. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1313-L1323.PubMedGoogle Scholar
  35. 35.
    Carroll NG, Mutavdzic S, James AL: Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002, 19:879–885.PubMedCrossRefGoogle Scholar
  36. 36.
    Brannan JD, Gulliksson M, Anderson SD, et al.: Eformoterol fumarate and sodium cromoglycate (SCG) inhibit the airway response to inhaled mannitol in asthmatics by mast cell inhibition (abstract). J Allergy Clin Immunol 2004, 113(2).Google Scholar
  37. 37.
    Crummy F, Livingston M, Ennis M, et al.: Mast cell mediator release in non-asthmatic subjects after endobronchial adenosine challenge. J Allergy Clin Immunol 2004, 114:34–39.PubMedCrossRefGoogle Scholar
  38. 38.
    Kalra S, Swystun VA, Bhagat R, et al.: Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996, 109:953–956.PubMedGoogle Scholar
  39. 39.
    Chong LK, Suvarna K, Chess-Williams R, et al.: Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol 2003, 138:512–520.PubMedCrossRefGoogle Scholar
  40. 40.
    Scola AM, Chong LK, Suvarna SK, et al.: Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmac 2004, 141:163–171.CrossRefGoogle Scholar
  41. 41.
    Anderson SD, Brannan JD: Long-acting beta2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future. Paediatr Drugs 2004, 6:161–175.PubMedCrossRefGoogle Scholar
  42. 42.
    Evans DW, Salome CM, King GG, et al.: Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects. Thorax 1997, 52:136–142.PubMedCrossRefGoogle Scholar
  43. 43.
    Aldridge RE, Hancox RJ, Robin Taylor D, et al.: Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma. Am J Respir Crit Care Med 2000, 161:1459–1464.PubMedGoogle Scholar
  44. 44.
    Polosa R, Ciamarra I, Mangano G, et al.: Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000, 15:30–35.PubMedCrossRefGoogle Scholar
  45. 45.
    Hancox RJ, Subbarao P, Kamada D, et al.: Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002, 165:1068–1070.PubMedGoogle Scholar
  46. 46.
    Swystun VA, Gordon JR, Davis EB, et al.: Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000, 106:57–64.PubMedCrossRefGoogle Scholar
  47. 47.
    Anderson SD, Brannan JD: Methods for ‘indirect’ challenge tests including exercise, eucapnic voluntary hyperpnea and hypertonic aerosols. Clin Rev Allergy Immunol 2003, 24:63–90.Google Scholar
  48. 48.
    Mannix ET, Manfredi F, Farber MO: A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters. Chest 1999, 115:649–653.PubMedCrossRefGoogle Scholar
  49. 49.
    Holzer K, Anderson SD, Chan H-K, et al.: Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003, 167:534–547.PubMedCrossRefGoogle Scholar
  50. 50.
    Rundell KW, Anderson SD, Spiering BA, et al.: Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest 2004, 125:909–915.PubMedCrossRefGoogle Scholar
  51. 51.
    Brannan JD, Koskela H, Anderson SD, et al.: Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med 1998, 158:1120–1126.PubMedGoogle Scholar
  52. 52.
    Anderson SD, Brannan J, Spring J, et al.: A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997, 156:758–765.PubMedGoogle Scholar
  53. 53.
    Koskela H, Di Sciascio M, Anderson SD, et al.: Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement. Clin Exp Allergy 2000, 30:1627–1636.PubMedCrossRefGoogle Scholar
  54. 54.
    Kanazawa H, Asai K, Hirata K, et al.: Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 2002, 122:166–170.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Sandra D. Anderson
    • 1
  • Pascale Kippelen
    • 1
  1. 1.Department of Respiratory MedicineCamperdownAustralia

Personalised recommendations